Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market by Type (OTC, Rx Drugs), By Application (Hospital, Retail Pharmacy) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market by Type (OTC, Rx Drugs), By Application (Hospital, Retail Pharmacy) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 171699 3300 Pharma & Healthcare 377 237 Pages 4.6 (34)
                                          

The global glycogen metabolism and glycogen storage disease treatment market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of metabolic disorders such as diabetes mellitus type 2, obesity, and cardiovascular diseases. These conditions are associated with increased risk for developing glycogen storage diseases such as McArdle's disease and Pompe's disease. The increase in awareness about these conditions among patients has led to an increase in demand for treatments that can help manage symptoms associated with these conditions. The global glycogen metabolism and glycogen storage disease treatment market by type includes over-the-counter (OTC) drugs and prescription drugs. OTC drugs are more popular than prescription drugs due to their lower cost, ease of availability, and fewer side effects when compared with prescription drugs. Prescription drug sales are expected to grow at a CAGR of 6% during the forecast period due to increasing prevalence rates for metabolic disorders such as diabetes mellitus type 2, obesity, cardiovascular diseases which lead to increased risk for developing glycogen storage diseases like McArdle's Disease or Pompe Disease which require treatment through prescription medications.

Some Of The Growth Factors Of This Market:

  1. The increasing prevalence of diabetes and obesity is driving the growth of the Glycogen Metabolism and Glycogen Storage Disease Treatment market.
  2. The increase in awareness about health issues related to diabetes has led to an increase in demand for treatments for this disease, which is driving the growth of the Glycogen Metabolism and Glycogen Storage Disease Treatment market.

Industry Growth Insights published a new data on “Glycogen Metabolism and Glycogen Storage Disease Treatment Market”. The research report is titled “Glycogen Metabolism and Glycogen Storage Disease Treatment Market research by Types (OTC, Rx Drugs), By Applications (Hospital, Retail Pharmacy), By Players/Companies Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Beohrigher Ingelheim, KOWA, Kythera, Fuji yakuhin, LG Chem, Mitsubishi Chemical”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Glycogen Metabolism and Glycogen Storage Disease Treatment Market Research Report

By Type

OTC, Rx Drugs

By Application

Hospital, Retail Pharmacy

By Companies

Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Beohrigher Ingelheim, KOWA, Kythera, Fuji yakuhin, LG Chem, Mitsubishi Chemical

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

237

Number of Tables & Figures

166

Customization Available

Yes, the report can be customized as per your need.


Global Glycogen Metabolism and Glycogen Storage Disease Treatment Industry Outlook


Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Report Segments:

The global Glycogen Metabolism and Glycogen Storage Disease Treatment market is segmented on the basis of:

Types

OTC, Rx Drugs

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Retail Pharmacy

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Merck
  2. Novartis
  3. Takeda Pharmaceutical
  4. Astra Zeneca
  5. Beohrigher Ingelheim
  6. KOWA
  7. Kythera
  8. Fuji yakuhin
  9. LG Chem
  10. Mitsubishi Chemical

Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Overview


Highlights of The Glycogen Metabolism and Glycogen Storage Disease Treatment Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. OTC
    2. Rx Drugs
  1. By Application:

    1. Hospital
    2. Retail Pharmacy
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Glycogen Metabolism and Glycogen Storage Disease Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Glycogen metabolism is the process by which glycogen is converted into glucose. Glycogen storage disease (GSD) is a group of disorders that result from problems with glycogen metabolism. These disorders can cause serious health problems, including seizures, coma, and death. Treatment for GSD typically includes medications to help improve glycemic control and reduce the amount of glycogen in the body.

Some of the key players operating in the glycogen metabolism and glycogen storage disease treatment market are Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Beohrigher Ingelheim, KOWA, Kythera, Fuji yakuhin, LG Chem, Mitsubishi Chemical.

The glycogen metabolism and glycogen storage disease treatment market is expected to grow at a compound annual growth rate of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Glycogen Metabolism and Glycogen Storage Disease Treatment Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Glycogen Metabolism and Glycogen Storage Disease Treatment Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Glycogen Metabolism and Glycogen Storage Disease Treatment Market - Supply Chain
   4.5. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Forecast
      4.5.1. Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Glycogen Metabolism and Glycogen Storage Disease Treatment Market Absolute $ Opportunity

5. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Type
      5.3.1. OTC
      5.3.2. Rx Drugs
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Application
      6.3.1. Hospital
      6.3.2. Retail Pharmacy
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Demand Share Forecast, 2019-2026

9. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Application
      9.4.1. Hospital
      9.4.2. Retail Pharmacy
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Type
      9.7.1. OTC
      9.7.2. Rx Drugs
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Glycogen Metabolism and Glycogen Storage Disease Treatment Demand Share Forecast, 2019-2026

10. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Application
      10.4.1. Hospital
      10.4.2. Retail Pharmacy
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Type
      10.7.1. OTC
      10.7.2. Rx Drugs
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Glycogen Metabolism and Glycogen Storage Disease Treatment Demand Share Forecast, 2019-2026

11. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Application
      11.4.1. Hospital
      11.4.2. Retail Pharmacy
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Applicaion
   11.7. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Type
      11.7.1. OTC
      11.7.2. Rx Drugs
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Glycogen Metabolism and Glycogen Storage Disease Treatment Demand Share, 2019-2026

12. Asia Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Application
      12.4.1. Hospital
      12.4.2. Retail Pharmacy
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Type
      12.7.1. OTC
      12.7.2. Rx Drugs
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Glycogen Metabolism and Glycogen Storage Disease Treatment Demand Share, 2019-2026

13. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Application
      13.4.1. Hospital
      13.4.2. Retail Pharmacy
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size and Volume Forecast by Type
      13.7.1. OTC
      13.7.2. Rx Drugs
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Glycogen Metabolism and Glycogen Storage Disease Treatment Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market: Market Share Analysis
   14.2. Glycogen Metabolism and Glycogen Storage Disease Treatment Distributors and Customers
   14.3. Glycogen Metabolism and Glycogen Storage Disease Treatment Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Merck
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Novartis
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Takeda Pharmaceutical
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Astra Zeneca
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Beohrigher Ingelheim
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. KOWA
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Kythera
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Fuji yakuhin
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. LG Chem
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Mitsubishi Chemical
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us